Evidence map›Paper›PMID 34946512›Full record

ReviewMolecules (Basel, Switzerland)2021

Herbal Products Used in Menopause and for Gynecological Disorders.

Maša Kenda, Nina Kočevar Glavač, Milan Nagy, Marija Sollner Dolenc, On Behalf Of The Oemonom

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Review
  3. Effect ofWorld journal of clinical cases · 2025
    Article
  4. Effects of Integrated Extracts ofAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. The Use ofBiomedicines · 2024
    Review
  8. The Different Phytochemical Profiles ofMolecules (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. An Updated Review of the GenusPlants (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maša KendaUniversity of Ljubljana, Faculty of Pharmacy, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.
Nina Kočevar GlavačUniversity of Ljubljana, Faculty of Pharmacy, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.
Milan NagyComenius University in Bratislava, Faculty of Pharmacy, 83232 Bratislava, Slovakia.
Marija Sollner DolencUniversity of Ljubljana, Faculty of Pharmacy, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0560-3762
On Behalf Of The Oemonom

Funding

the Erasmus+ Programme of the European Union Project No. 2020-1-CZ01-KA203-078218
6 · The paper itself

Abstract

Herbal products are often used as an alternative to pharmacological therapy. Menopausal symptoms and gynecological disorders (such as premenstrual syndrome and dysmenorrhea) are the indications where pharmacological therapy may have serious adverse events, hence many women prefer to use herbal products to help with these symptoms. Here, we reviewed plants and derived products, which are commonly used for the abovementioned indications, focusing on clinical data, safely profile and whether or not their use is justified. We noted that limited data are available on the use of some plants for alleviating the symptoms of menopause and gynecological disorders. While black cohosh (

Indexed as

PhytotherapyPlants, MedicinalDysmenorrheaFemaleHumansMenopausePremenstrual Syndromedysmenorrheagynecological disordersherbal productsmedicinal plantsmenopausepremenstrual syndrome

Identifiers

PMID34946512
PMCPMC8708702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.